Skip to main content
Toggle navigation
Login
Search
Home
Tweets by SSO 2024 Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded for On-Demand Viewing
Back
Tweet
Tibor Keler, PhD
Executive Vice President and Chief Scientific Officer
Celldex Therapeutics, Hampton, NJ
Poster(s):
E193: Expanding immunotherapy options in cholangiocarcinoma: Role of CD27 agonist in combination with PD-L1 and MEK inhibition on antitumor effect and CD8+ T cells
